Dong Il Won1, Jang Soo Suh. 1. Department of Clinical Pathology, Kyungpook National University School of Medicine, Daegu, Republic of Korea. wondi@knu.ac.kr
Abstract
BACKGROUND: Hereditary spherocytosis (HS) is the most common cause of inherited chronic hemolysis. The various tests developed for HS screening have many shortcomings. The purpose of this study was to develop a new, simple, reliable test using flow cytometry. METHODS: In this new test, deionized water, a hemolysis-inducing agent, is spiked to a red cell suspension during acquisition, and the count of red cells is measured sequentially in real-time using flow cytometry. In this study, the optimal parameters for this test were established, and the discriminatory power of the adopted protocol was verified among several groups with various degrees of osmotic fragility (OF). RESULTS: The established protocol successfully discriminated between blood analyzed immediately and blood stored for 24 h (P < 0.00001). With healthy individuals as a reference, the OF measured by this protocol was significantly decreased in patients with iron deficiency anemia (P = 0.030) and was significantly increased in HS patients (P = 1.1 x 10(-9)). This new test found all 11 HS patients to have increased OF. CONCLUSIONS: This new test was verified to be simple, quantitative, objective, and cost-effective for the measurement of OF. We suggest this test as another effective approach for HS screening, although its assay performance will require further verification through more clinical trials. 2008 Clinical Cytometry Society.
BACKGROUND:Hereditary spherocytosis (HS) is the most common cause of inherited chronic hemolysis. The various tests developed for HS screening have many shortcomings. The purpose of this study was to develop a new, simple, reliable test using flow cytometry. METHODS: In this new test, deionized water, a hemolysis-inducing agent, is spiked to a red cell suspension during acquisition, and the count of red cells is measured sequentially in real-time using flow cytometry. In this study, the optimal parameters for this test were established, and the discriminatory power of the adopted protocol was verified among several groups with various degrees of osmotic fragility (OF). RESULTS: The established protocol successfully discriminated between blood analyzed immediately and blood stored for 24 h (P < 0.00001). With healthy individuals as a reference, the OF measured by this protocol was significantly decreased in patients with iron deficiency anemia (P = 0.030) and was significantly increased in HSpatients (P = 1.1 x 10(-9)). This new test found all 11 HSpatients to have increased OF. CONCLUSIONS: This new test was verified to be simple, quantitative, objective, and cost-effective for the measurement of OF. We suggest this test as another effective approach for HS screening, although its assay performance will require further verification through more clinical trials. 2008 Clinical Cytometry Society.
Authors: Hee Won Chueh; Sang Mee Hwang; Ye Jee Shim; Jae Min Lee; Hee Sue Park; Joon Hee Lee; Youngwon Nam; Namhee Kim; Hye Lim Jung; Hyoung Soo Choi Journal: Blood Res Date: 2022-05-20
Authors: William P Clafshenkel; Hironobu Murata; Jill Andersen; Yehuda Creeger; Richard R Koepsel; Alan J Russell Journal: PLoS One Date: 2016-06-22 Impact factor: 3.240
Authors: Ye Jee Shim; Hye Lim Jung; Hee Young Shin; Hyoung Jin Kang; Jung Yoon Choi; Jeong Ok Hah; Jae Min Lee; Young Tak Lim; Eu Jeen Yang; Hee Jo Baek; Hyoung Soo Choi; Keon Hee Yoo; Jun Eun Park; Seongkoo Kim; Ji Yoon Kim; Eun Sil Park; Ho Joon Im; Hee Won Chueh; Soon Ki Kim; Jae Hee Lee; Eun Sun Yoo; Hyeon Jin Park; Jun Ah Lee; Meerim Park; Hyun Sik Kang; Ji Kyoung Park; Na Hee Lee; Sang Kyu Park; Young Ho Lee; Seong Wook Lee; Eun Jin Choi; Seom Gim Kong Journal: J Korean Med Sci Date: 2020-08-24 Impact factor: 2.153